All Parkinson's disease articles
-
Formulary decision guideIpinnia® XL (ropinirole hydrochloride) prolonged-release tablets
This formulary decision guide was commissioned by Ethypharm and developed from content provided by Ethypharm in a format developed by Guidelines in Practice.
View prescribing and adverse event reporting information
For UK healthcare professionals only.
UK-IPN-13 Date of preparation: September 2021 -
Top tips
Top tips: Parkinson’s disease
Dr Shahid Dadabhoy discusses some key points in the diagnosis and management of Parkinson’s disease in primary care
-
News
NICE updates Parkinson’s disease in adults guideline
NICE has published an update to NICE Guideline (NG) 71 on Parkinson’s disease in adults.
-
Implementing guidelines
Suspected Parkinson's disease should be referred untreated
Dr Katherine Grosset (left), Dr Graeme Macphee, and Dr Donald Grosset review the SIGN guideline on the diagnosis and pharmacological management of Parkinson’s disease
-
Personal view
PD guidance from NICE has been difficult to implement
Dr Chris Taggart revisits the NICE Parkinson s disease guideline to assess whether its key priorities have been addressed locally
-
Implementing guidelines
Communication is key with your Parkinson's disease patients
Dr John Hindle discusses the PD guidance from NICE, which promotes quick referral to a specialist for diagnosis and management of non-motor symptoms
-
Implementing guidelines
Parkinson's disease patients should be referred untreated
The NICE PD guideline recommends that GPs leave diagnosis and treatment to specialists, explains Dr Chris Taggart
